亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Patients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis

医学 荟萃分析 科克伦图书馆 系统回顾 梅德林 外科 干预(咨询) 内科学 政治学 精神科 法学
作者
Lazaros Tzelves,Robert Geraghty,Riccardo Lombardo,Niall F. Davis,Aleš Petřík,Andreas Neisius,Giovanni Gambaro,Christian Türk,Kay Thomas,Bhaskar Somani,Andreas Skolarikos
出处
期刊:European urology focus [Elsevier BV]
卷期号:9 (1): 188-198 被引量:52
标识
DOI:10.1016/j.euf.2022.06.016
摘要

No algorithm exists for structured follow-up of urolithiasis patients.To provide a discharge time point during follow-up of urolithiasis patients after treatment.We performed a systematic review of PubMed/Medline, EMBASE, Cochrane Library, clinicaltrials.gov, and reference lists according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. Fifty studies were eligible.From a pooled analysis of 5467 stone-free patients, we estimated that for a safety margin of 80% for remaining stone free, patients should be followed up using imaging, for at least 2 yr (radiopaque stones) or 3 yr (radiolucent stones) before being discharged. Patients should be discharged after 5 yr of no recurrence with a safety margin of 90%. Regarding residual disease, patients with fragments ≤4 mm could be offered surveillance up to 4 yr since intervention rates range between 17% and 29%, disease progression between 9% and 34%, and spontaneous passage between 21% and 34% at 49 mo. Patients with larger residual fragments should be offered further definitive intervention since intervention rates are high (24-100%). Insufficient data exist for high-risk patients, but the current literature dictates that patients who are adherent to targeted medical treatment seem to experience less stone growth or regrowth of residual fragments, and may be discharged after 36-48 mo of nonprogressive disease on imaging.This systematic review and meta-analysis indicates that stone-free patients with radiopaque or radiolucent stones should be followed up to 2 or 3 yr, respectively. In patients with residual fragments ≤4 mm, surveillance or intervention can be advised according to patient preferences and characteristics, while for those with larger residual fragments, reintervention should be scheduled.Here, we review the literature regarding follow-up of urolithiasis patients. Patients who have no stones after treatment should be seen up to 2-3 yr, those with large fragments should be reoperated, and those with small fragments could be offered surveillance with imaging.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
vavel发布了新的文献求助10
10秒前
daihq3完成签到,获得积分10
11秒前
美丽小虾米完成签到,获得积分10
11秒前
19秒前
李健的小迷弟的应助被nian采纳,获得10
19秒前
yzr01完成签到,获得积分10
22秒前
隐形曼青的应助被vavel采纳,获得10
23秒前
26秒前
28秒前
32秒前
CC完成签到,获得积分10
33秒前
biye发布了新的文献求助50
35秒前
开放的子默完成签到,获得积分10
54秒前
如初完成签到,获得积分10
55秒前
戴肉肉完成签到 ,获得积分10
57秒前
初心完成签到,获得积分10
1分钟前
巧克力豆丁好好吃完成签到,获得积分10
1分钟前
1分钟前
谦让的代桃完成签到 ,获得积分10
1分钟前
cen发布了新的文献求助10
1分钟前
NexusExplorer的应助被blue采纳,获得10
1分钟前
感动晓亦完成签到,获得积分10
1分钟前
腼腆的夏蓉完成签到,获得积分10
1分钟前
j7完成签到,获得积分10
1分钟前
CRUSADER发布了新的文献求助10
1分钟前
张张完成签到,获得积分10
2分钟前
2分钟前
谷雨发布了新的文献求助20
2分钟前
明亮葶完成签到,获得积分10
2分钟前
搜集达人的应助被开朗紫采纳,获得10
2分钟前
栖湖知鱼完成签到,获得积分10
2分钟前
爱听歌的碧彤完成签到,获得积分10
2分钟前
学不完了完成签到 ,获得积分10
2分钟前
2分钟前
开朗紫发布了新的文献求助10
2分钟前
flysteven92完成签到 ,获得积分10
3分钟前
Explosion完成签到 ,获得积分10
3分钟前
闪闪书蕾完成签到,获得积分10
3分钟前
欣慰的雨旋完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
Organizational Behavior 510
Management and the Arts 510
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 1: A–B 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7792137
求助须知:如何正确求助?哪些是违规求助? 9329313
关于积分的说明 20427600
捐赠科研通 7381691
什么是DOI,文献DOI怎么找? 3323598
关于科研通互助平台的介绍 2471463
邀请新用户注册赠送积分活动 2340741